1 min read
Meet Veristat at PHUSE US Connect: Advancing Data-Driven Clinical Development
🔬 Connecting with the Global Clinical Data and Biostatistics Community
Veristat is pleased to attend PHUSE US Connect...
Apples to Apples: Playing the Comparability Game in Biotherapeutics Development
Comparability studies are a significant issue for those working in biotherapeutics development, as undetected product changes are considered high risk.
Listen to the full episode on Veristat’s Advancing Revolutionary Therapies Podcast to get important insights and recommendations on how to successfully plan your clinical and CMC manufacturing development plans to reduce your regulatory risk along the way.
Learning Points
- The importance of comparability studies for biologics
- Key aspects of a comparability assessment
- How to determine analytical and stability parameters when measuring comparability
- Conditions for evaluating stability studies
Meet Veristat. Learn More.
Get the Latest News
Categories
- Regulatory Consulting (133)
- Regulatory Submissions (126)
- Clinical Trial Regulations (117)
- COVID-19 (46)
- Strategic Consulting (38)
- Clinical Trials (33)
- Life At Veristat (21)
- Oncology (18)
- Events (16)
- Success Stories (13)
- Project Management (11)
- Clinical Operations/Monitoring (10)
- Decentralized Trials/Virtual Trials (9)
- Full-Service (9)
- Medical Writing (9)
- CMC (6)
- Data Management (5)
- Marketing Applications (5)
- Adaptive Design (4)
- Statistics and Programming (4)
- Biologics (3)
- Cell Gene and RNA (3)
- Biometrics (2)
- Natural History (2)
- Neurology/CNS (2)
- Rare Diseases (2)
- Hematology (1)
- Medical Affairs (1)